<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Prospective Grant of Exclusive Patent License: Use of Scopolamine to Treat Depression</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Prospective Grant of Exclusive Patent License: Use of Scopolamine to Treat Depression</h1>
    <p class="timestamp">Published: 2013-08-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>This notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to Antares Pharma Inc., a company having a place of business in Ewing, New Jersey, to practice the inventions embodied in the following patent applications and patents: 1. U.S. Patent Application 11/137,114, filed May 25, 2005, titled "Scopolamine for the Treatment of Depression and Anxiety" [...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, National Institutes of Health</p>
    <p><strong>Document Number:</strong> 2013-20880</p>
    <p><strong>Publication Date:</strong> 2013-08-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/08/27/2013-20880/prospective-grant-of-exclusive-patent-license-use-of-scopolamine-to-treat-depression">https://www.federalregister.gov/documents/2013/08/27/2013-20880/prospective-grant-of-exclusive-patent-license-use-of-scopolamine-to-treat-depression</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-20880</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
